NEWM&A

Adial Pharmaceuticals (ADIL) Acquires Azora Therapeutics for $32M

Published on 6/11/2026

#ADIL#M&A
Adial Pharmaceuticals (ADIL) Acquires Azora Therapeutics for $32M

AI Summary

Adial Pharmaceuticals (ADIL) has acquired Azora Therapeutics for $32 million. This transaction is significant as it may broaden ADIL's portfolio and enhance its market presence. The deal could potentially impact ADIL's stock performance depending on the synergies and future revenues generated from Azora. Investors will be watching closely for any updates regarding the integration of the newly acquired assets.

Source: Read original article (opens in new tab)

Related News

Triller Group (TRLR) Shareholders Approve Reverse Stock Split
M&A

Triller Group (TRLR) Shareholders Approve Reverse Stock Split

Jun 11

Hugo Boss (HUGO) Shares Rise 7% After €2 Billion Takeover Bid
M&A

Hugo Boss (HUGO) Shares Rise 7% After €2 Billion Takeover Bid

Jun 11

MSAB Becomes Largest Beijer Ref Shareholder by Voting Rights
M&A

MSAB Becomes Largest Beijer Ref Shareholder by Voting Rights

Jun 11

Hugo Boss (BOSS) stock rises after €2.7bn Frasers Group offer
M&A

Hugo Boss (BOSS) stock rises after €2.7bn Frasers Group offer

Jun 11